References
- Wolf G, Long D, Riess J. Percutaneous lymphography with PFOB. Radiology 1990; 177(P)366
- Wolf GL. Indirect lymphography with radioopaque nanoparticulates. Radiology 1992; 185(P)115
- Weidner N., Folkman J., Pozza F., et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992; 84: 1875–1887
- Boucher Y, Jain RK. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 1992; 52: 5110–5114
- Eskey CJ, Koretsky AP, Domach MM, Jain RK. 2H-nuclear magnetic resonance imaging of tumor blood flow: spatial and temporal heterogeneity in a tissue-isolated mammary adenocarcinoma. Cancer Res 1992; 52: 6010–6019
- Kuhnle GEH, Dellian M, Walenta S, Mueller-Klieser W, Guetz AE. Simultaneous high-resolution measurement of adenosine triphosphate levels and blood flow in hamster amelanotic melanoma A-mel-3. J Natl Cancer Inst 1992; 84: 1642–1647
- Davis PL, Wolf GL, Gillen J. Indicator dilution time-activity curves demonstrated by rapid magnetic resonance imaging techniques and paramagnetic contrast agent. Invest Radiol 1989; 24: 400–406
- Rosen BR, Belliveau JW, Chien D. Perfusion imaging with nuclear magnetic resonance. Magn Reson Q 1989; 5: 263–281
- Wolf GL, Rogowska J. Contrast agents for fast imaging. Magn Reson Med 1991; 22: 268–272
- Stack JP, Redmond OM, Codd MB, Dervan PA, Ennis JT. Breast disease: tissue characterization with Gd-DTPA enhancement profiles. Radiology 1990; 174: 491–494
- Jain RK. Delivery of novel therapeutic agents in tumors: physiologic barriers and strategies. J Natl Cancer Inst 1989; 81: 570–576
- Kenney J, Schmiedl U, Maravilla K, Starr F, Graham M, Spence A, Nelson J. Measurement of blood-brain barrier permeability in a tumor model using magnetic resonance imaging with gadolinium DTPA. Magn Reson Med 1992; 27: 68–75